125 related articles for article (PubMed ID: 17850576)
1. Increased systemic vascular resistance in Atlantic salmon, Salmo salar L., affected with amoebic gill disease.
Leef MJ; Hill JV; Harris JO; Powell MD
J Fish Dis; 2007 Oct; 30(10):601-13. PubMed ID: 17850576
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular responses of three salmonid species affected with amoebic gill disease (AGD).
Leef MJ; Harris JO; Hill J; Powell MD
J Comp Physiol B; 2005 Oct; 175(7):523-32. PubMed ID: 16088392
[TBL] [Abstract][Full Text] [Related]
3. Coordinated down-regulation of the antigen processing machinery in the gills of amoebic gill disease-affected Atlantic salmon (Salmo salar L.).
Young ND; Cooper GA; Nowak BF; Koop BF; Morrison RN
Mol Immunol; 2008 May; 45(9):2581-97. PubMed ID: 18282602
[TBL] [Abstract][Full Text] [Related]
4. Metabolic effects of amoebic gill disease (AGD) and chloramine-T exposure in seawater-acclimated Atlantic salmon Salmo salar.
Leef MJ; Harris JO; Powell MD
Dis Aquat Organ; 2007 Oct; 78(1):37-44. PubMed ID: 18159671
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analyses of amoebic gill disease-affected Atlantic salmon (Salmo salar) tissues reveal localized host gene suppression.
Wynne JW; O'Sullivan MG; Cook MT; Stone G; Nowak BF; Lovell DR; Elliott NG
Mar Biotechnol (NY); 2008; 10(4):388-403. PubMed ID: 18219527
[TBL] [Abstract][Full Text] [Related]
6. MHC class II+ cells in the gills of Atlantic salmon (Salmo salar L.) affected by amoebic gill disease.
Morrison RN; Koppang EO; Hordvik I; Nowak BF
Vet Immunol Immunopathol; 2006 Feb; 109(3-4):297-303. PubMed ID: 16182375
[TBL] [Abstract][Full Text] [Related]
7. Respiratory pathogenesis of amoebic gill disease (AGD) in experimentally infected Atlantic salmon Salmo salar.
Leef MJ; Harris JO; Powell MD
Dis Aquat Organ; 2005 Sep; 66(3):205-13. PubMed ID: 16261935
[TBL] [Abstract][Full Text] [Related]
8. A diversity of amoebae colonise the gills of farmed Atlantic salmon (Salmo salar) with amoebic gill disease (AGD).
English CJ; Tyml T; Botwright NA; Barnes AC; Wynne JW; Lima PC; Cook MT
Eur J Protistol; 2019 Feb; 67():27-45. PubMed ID: 30447480
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome profiling the gills of amoebic gill disease (AGD)-affected Atlantic salmon (Salmo salar L.): a role for tumor suppressor p53 in AGD pathogenesis?
Morrison RN; Cooper GA; Koop BF; Rise ML; Bridle AR; Adams MB; Nowak BF
Physiol Genomics; 2006 Jun; 26(1):15-34. PubMed ID: 16493018
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed proteins in gill and skin mucus of Atlantic salmon (Salmo salar) affected by amoebic gill disease.
Valdenegro-Vega VA; Crosbie P; Bridle A; Leef M; Wilson R; Nowak BF
Fish Shellfish Immunol; 2014 Sep; 40(1):69-77. PubMed ID: 24979223
[TBL] [Abstract][Full Text] [Related]
11. Comparative ionic flux and gill mucous cell histochemistry: effects of salinity and disease status in Atlantic salmon (Salmo salar L.).
Roberts SD; Powell MD
Comp Biochem Physiol A Mol Integr Physiol; 2003 Mar; 134(3):525-37. PubMed ID: 12600661
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of immune response gene expression and cellular localisation of interleukin-1beta mRNA in Atlantic salmon, Salmo salar L., affected by amoebic gill disease (AGD).
Bridle AR; Morrison RN; Cupit Cunningham PM; Nowak BF
Vet Immunol Immunopathol; 2006 Nov; 114(1-2):121-34. PubMed ID: 16956669
[TBL] [Abstract][Full Text] [Related]
13. Neoparamoeba perurans n. sp., an agent of amoebic gill disease of Atlantic salmon (Salmo salar).
Young ND; Crosbie PB; Adams MB; Nowak BF; Morrison RN
Int J Parasitol; 2007 Nov; 37(13):1469-81. PubMed ID: 17561022
[TBL] [Abstract][Full Text] [Related]
14. Amoebic gill disease (AGD)-affected Atlantic salmon, Salmo salar L., are resistant to subsequent AGD challenge.
Vincent BN; Morrison RN; Nowak BF
J Fish Dis; 2006 Sep; 29(9):549-59. PubMed ID: 16948705
[TBL] [Abstract][Full Text] [Related]
15. Oral L-cysteine ethyl ester (LCEE) reduces amoebic gill disease (AGD) in Atlantic salmon Salmo salar.
Roberts SD; Powell MD
Dis Aquat Organ; 2005 Aug; 66(1):21-8. PubMed ID: 16175964
[TBL] [Abstract][Full Text] [Related]
16. Effects of single and repeated infections with Neoparamoeba perurans on antibody levels and immune gene expression in Atlantic salmon (Salmo salar).
Valdenegro-Vega VA; Polinski M; Bridle A; Crosbie P; Leef M; Nowak BF
Fish Shellfish Immunol; 2015 Feb; 42(2):522-9. PubMed ID: 25433137
[TBL] [Abstract][Full Text] [Related]
17. Further development of bithionol therapy as a treatment for amoebic gill disease in Atlantic salmon, Salmo salar L.
Florent RL; Becker J; Powell MD
J Fish Dis; 2009 May; 32(5):391-400. PubMed ID: 19243491
[TBL] [Abstract][Full Text] [Related]
18. A comparison of disease susceptibility and innate immune response between diploid and triploid Atlantic salmon (Salmo salar) siblings following experimental infection with Neoparamoeba perurans, causative agent of amoebic gill disease.
Chalmers L; Taylor JF; Roy W; Preston AC; Migaud H; Adams A
Parasitology; 2017 Aug; 144(9):1229-1242. PubMed ID: 28492111
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and expression analysis of tumour necrosis factor-alpha in amoebic gill disease (AGD)-affected Atlantic salmon (Salmo salar L.).
Morrison RN; Zou J; Secombes CJ; Scapigliati G; Adams MB; Nowak BF
Fish Shellfish Immunol; 2007 Nov; 23(5):1015-31. PubMed ID: 17566761
[TBL] [Abstract][Full Text] [Related]
20. Reduced total hardness of fresh water enhances the efficacy of bathing as a treatment for amoebic gill disease in Atlantic salmon, Salmo salar L.
Roberts SD; Powell MD
J Fish Dis; 2003 Oct; 26(10):591-9. PubMed ID: 14653317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
